BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
2.260
+0.125 (5.85%)
At close: Nov 22, 2024, 4:00 PM
2.300
+0.040 (1.77%)
After-hours: Nov 22, 2024, 5:26 PM EST
BioCardia Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 0.07 | 0.48 | 1.35 | 1.02 | 0.15 | 0.71 | |
| Revenue Growth (YoY) | -87.54% | -64.72% | 33.20% | 600.00% | -79.58% | 13.60% | |
| Cost of Revenue | 7.73 | 7.73 | 8.83 | 8.56 | 9.81 | 8.92 | |
| Gross Profit | -7.66 | -7.25 | -7.48 | -7.54 | -9.67 | -8.21 | |
| Selling, General & Admin | 3.71 | 4.4 | 4.42 | 5.09 | 5.86 | 6 | |
| Operating Expenses | 0.11 | 4.4 | 4.42 | 5.09 | 5.86 | 6 | |
| Operating Income | -7.76 | -11.64 | -11.9 | -12.63 | -15.53 | -14.21 | |
| Interest Expense | - | - | - | - | -0 | -0.11 | |
| Interest & Investment Income | 0.07 | 0.07 | - | - | 0.02 | 0.09 | |
| Other Non Operating Income (Expenses) | -0.03 | - | -0.01 | 0.01 | -0 | -0 | |
| EBT Excluding Unusual Items | -7.72 | -11.57 | -11.91 | -12.62 | -15.51 | -14.24 | |
| Other Unusual Items | - | - | - | - | 0.51 | -0.47 | |
| Pretax Income | -7.72 | -11.57 | -11.91 | -12.62 | -15 | -14.71 | |
| Net Income | -7.72 | -11.57 | -11.91 | -12.62 | -15 | -14.71 | |
| Net Income to Common | -7.72 | -11.57 | -11.91 | -12.62 | -15 | -14.71 | |
| Shares Outstanding (Basic) | 2 | 1 | 1 | 1 | 1 | 0 | |
| Shares Outstanding (Diluted) | 2 | 1 | 1 | 1 | 1 | 0 | |
| Shares Change (YoY) | 47.00% | 19.52% | 4.75% | 67.19% | 79.27% | 32.37% | |
| EPS (Basic) | -3.92 | -8.19 | -10.08 | -11.19 | -22.24 | -39.09 | |
| EPS (Diluted) | -3.92 | -8.19 | -10.08 | -11.19 | -22.24 | -39.09 | |
| Free Cash Flow | -7.31 | -9.99 | -10.63 | -10.48 | -12.39 | -9.59 | |
| Free Cash Flow Per Share | -3.71 | -7.07 | -9.00 | -9.29 | -18.37 | -25.49 | |
| Operating Margin | -10935.21% | -2441.09% | -880.25% | -1244.33% | -10709.66% | -2001.83% | |
| Profit Margin | -10876.06% | -2425.79% | -880.70% | -1243.65% | -10347.59% | -2071.69% | |
| Free Cash Flow Margin | -10294.37% | -2093.50% | -786.32% | -1032.71% | -8544.14% | -1350.85% | |
| EBITDA | -7.69 | -11.56 | -11.82 | -12.57 | -15.46 | -14.1 | |
| D&A For EBITDA | 0.07 | 0.08 | 0.08 | 0.06 | 0.07 | 0.11 | |
| EBIT | -7.76 | -11.64 | -11.9 | -12.63 | -15.53 | -14.21 | |
| Revenue as Reported | 0.48 | 0.48 | 1.35 | 1.02 | 0.15 | 0.71 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.